ArticleBMC primary care2026
Role of diagnostic testing in reducing unnecessary antibiotic use for upper respiratory tract infections in Chinese primary healthcare: a mixed-methods study.
Article in BMC primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundsAntimicrobial resistance (AMR) is a growing global concern, driven by inappropriate antibiotic use, particularly in primary healthcare(PHC). The treatment of upper respiratory tract infections (URTIs), which are mostly of viral etiology, is a major source of such misuse. Limited access to diagnostic tools may contribute to unnecessary prescribing. This study examines whether the availability of diagnostic tools reduces unnecessary antibiotic use for URTIs in primary healthcare settings of China, with particular attention to facility-level availability of C-reactive protein (CRP) testing.
methodsA mixed-methods approach was employed, integrating a cross-sectional survey of general practitioners (GPs) with an analysis of their prescription records and in-depth interviews with a subset of GPs. Quantitative analysis involved descriptive statistics and multilevel logistic regression to assess whether facility-level availability of CRP testing was associated with antibiotic prescribing for URTIs, whereas qualitative interviews explored the contextual influences on clinical decision-making.
resultsA total of 108 general practitioners from 30 PHC facilities filled out the questionnaires. Records of 12,489 prescriptions for URTI issued by these physicians were retrieved, of which 7,706 contained at least one antibiotic, with a URTI antibiotic prescribing rate of 61.7%. Among the 30 PHC facilities, 11 (36.7%) were equipped with CRP testing. Multilevel logistic regression models showed that CRP-test availability was associated with lower odds of antibiotic prescribing for URTIs (OR = 0.74; 95%CI:0.56-0.98; p = 0.033). Interviews with GPs revealed that limited access to diagnostic tools increased uncertainty in clinical decision-making, whereas access to such tools supported more evidence-informed prescribing and improved communication with patients.
conclusionsC-reactive protein testing and other diagnostic tools play an important role in enabling rational antibiotic prescribing in PHC facilities. Strengthening diagnostic capacity and ensuring ongoing professional training for GPs represent essential strategies to curb inappropriate antibiotic use, mitigating the progression of antimicrobial resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.